# Montauk Renewables, Inc.: financial statements, quarterly

MNTK · Nasdaq · CIK 1826600 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mntk.md) · [Financials](/companies/mntk/financials.md) · [Filings](/companies/mntk/filings.md) · [Insiders](/companies/mntk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mntk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.7](/filings/0000950170-24-125582.md) | [46.8 d](/filings/0001193125-26-102364.md) | [38.8](/filings/0000950170-25-067125.md) | [43.3](/filings/0000950170-25-104181.md) | [65.9](/filings/0001193125-25-267126.md) | [27.7 d](/filings/0001193125-26-102364.md) | [42.6](/filings/0001193125-26-209250.md) | [45.1](/filings/0001193125-26-335335.md) | [45.3](/filings/0001193125-25-267126.md) | [43.4 d](/filings/0001193125-26-102364.md) | [46.4](/filings/0001193125-26-209250.md) | [54.0](/filings/0001193125-26-335335.md) |
| Gross profit | $m | [22.4](/filings/0000950170-24-125582.md) | [13.0 d](/filings/0000950170-24-031587.md) | [8.9](/filings/0000950170-24-057177.md) | [6.7](/filings/0000950170-24-094128.md) | [28.9](/filings/0000950170-24-125582.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [16.8](/filings/0000950170-24-125582.md) | [7.5 d](/filings/0001193125-26-102364.md) | [2.4](/filings/0000950170-25-067125.md) | [0.9](/filings/0000950170-25-104181.md) | [22.7](/filings/0001193125-25-267126.md) | [(9.8) d](/filings/0001193125-26-102364.md) | [0.4](/filings/0001193125-26-209250.md) | [(2.4)](/filings/0001193125-26-335335.md) | [4.4](/filings/0001193125-25-267126.md) | [(1.6) d](/filings/0001193125-26-102364.md) | [(1.6)](/filings/0001193125-26-209250.md) | [(0.1)](/filings/0001193125-26-335335.md) |
| Interest expense | $m | [1.3](/filings/0000950170-24-125582.md) | [2.1 d](/filings/0000950170-24-031587.md) | [1.2](/filings/0000950170-24-057177.md) | [1.3](/filings/0000950170-24-094128.md) | [1.8](/filings/0000950170-24-125582.md) | [1.0 d](/filings/0001193125-26-102364.md) | [1.2](/filings/0001193125-26-209250.md) | [1.2](/filings/0001193125-26-335335.md) | [1.1](/filings/0001193125-25-267126.md) | [1.3 d](/filings/0001193125-26-102364.md) | [1.3](/filings/0001193125-26-209250.md) | [1.5](/filings/0001193125-26-335335.md) |
| Income tax | $m | [2.8](/filings/0000950170-24-125582.md) | [0.7 d](/filings/0001193125-26-102364.md) | [0.4](/filings/0000950170-25-067125.md) | [0.3](/filings/0000950170-25-104181.md) | [4.0](/filings/0001193125-25-267126.md) | [(2.3) d](/filings/0001193125-26-102364.md) | [(0.3)](/filings/0001193125-26-209250.md) | [1.9](/filings/0001193125-26-335335.md) | [(1.8)](/filings/0001193125-25-267126.md) | [(3.9) d](/filings/0001193125-26-102364.md) | [(0.3)](/filings/0001193125-26-209250.md) | [2.0](/filings/0001193125-26-335335.md) |
| Net income | $m | [12.9](/filings/0000950170-24-125582.md) | [4.8 d](/filings/0001193125-26-102364.md) | [1.9](/filings/0000950170-25-067125.md) | [(0.7)](/filings/0000950170-25-104181.md) | [17.0](/filings/0001193125-25-267126.md) | [(8.5) d](/filings/0001193125-26-102364.md) | [(0.5)](/filings/0001193125-26-209250.md) | [(5.5)](/filings/0001193125-26-335335.md) | [5.2](/filings/0001193125-25-267126.md) | [2.5 d](/filings/0001193125-26-102364.md) | [0.0](/filings/0001193125-26-209250.md) | [0.2](/filings/0001193125-26-335335.md) |
| Diluted EPS | $ per share | [0.09](/filings/0000950170-24-125582.md) | not reported | [0.01](/filings/0000950170-25-067125.md) | [(0.01)](/filings/0000950170-25-104181.md) | [0.12](/filings/0001193125-25-267126.md) | not reported | [0.00](/filings/0001193125-26-209250.md) | [(0.04)](/filings/0001193125-26-335335.md) | [0.04](/filings/0001193125-25-267126.md) | not reported | [0.00](/filings/0001193125-26-209250.md) | [0.00](/filings/0001193125-26-335335.md) |
| Basic EPS | $ per share | [0.09](/filings/0000950170-24-125582.md) | not reported | [0.01](/filings/0000950170-25-067125.md) | [(0.01)](/filings/0000950170-25-104181.md) | [0.12](/filings/0001193125-25-267126.md) | not reported | [0.00](/filings/0001193125-26-209250.md) | [(0.04)](/filings/0001193125-26-335335.md) | [0.04](/filings/0001193125-25-267126.md) | not reported | [0.00](/filings/0001193125-26-209250.md) | [0.00](/filings/0001193125-26-335335.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [73.3](/filings/0000950170-24-125582.md) | [73.8](/filings/0001193125-26-102364.md) | [63.3](/filings/0000950170-25-067125.md) | [42.3](/filings/0000950170-25-104181.md) | [55.0](/filings/0001193125-25-267126.md) | [45.6](/filings/0001193125-26-102364.md) | [40.1](/filings/0001193125-26-209250.md) | [29.1](/filings/0001193125-26-335335.md) | [6.8](/filings/0001193125-25-267126.md) | [23.8](/filings/0001193125-26-335335.md) | [25.9](/filings/0001193125-26-209250.md) | [15.8](/filings/0001193125-26-335335.md) |
| Current assets | $m | [107](/filings/0000950170-23-062166.md) | [90.2](/filings/0000950170-25-039495.md) | [76.6](/filings/0000950170-24-057177.md) | [71.1](/filings/0000950170-24-094128.md) | [79.3](/filings/0000950170-24-125582.md) | [57.2](/filings/0001193125-26-102364.md) | [52.2](/filings/0000950170-25-067125.md) | [42.6](/filings/0000950170-25-104181.md) | [18.0](/filings/0001193125-25-267126.md) | [37.2](/filings/0001193125-26-335335.md) | [35.7](/filings/0001193125-26-209250.md) | [27.3](/filings/0001193125-26-335335.md) |
| Total assets | $m | [346](/filings/0000950170-24-125582.md) | [350](/filings/0001193125-26-102364.md) | [355](/filings/0000950170-25-067125.md) | [362](/filings/0000950170-25-104181.md) | [374](/filings/0001193125-25-267126.md) | [349](/filings/0001193125-26-102364.md) | [354](/filings/0001193125-26-209250.md) | [382](/filings/0001193125-26-335335.md) | [383](/filings/0001193125-25-267126.md) | [435](/filings/0001193125-26-335335.md) | [468](/filings/0001193125-26-209250.md) | [471](/filings/0001193125-26-335335.md) |
| Current liabilities | $m | [30.2](/filings/0000950170-23-062166.md) | [29.4](/filings/0000950170-25-039495.md) | [33.8](/filings/0000950170-24-057177.md) | [42.9](/filings/0000950170-24-094128.md) | [38.9](/filings/0000950170-24-125582.md) | [33.5](/filings/0001193125-26-102364.md) | [41.0](/filings/0000950170-25-067125.md) | [55.5](/filings/0000950170-25-104181.md) | [53.9](/filings/0001193125-25-267126.md) | [33.4](/filings/0001193125-26-335335.md) | [42.0](/filings/0001193125-26-209250.md) | [44.3](/filings/0001193125-26-335335.md) |
| Total liabilities | $m | [102](/filings/0000950170-23-062166.md) | [100.0](/filings/0000950170-25-039495.md) | [100](/filings/0000950170-24-057177.md) | [107](/filings/0000950170-24-094128.md) | [98.8](/filings/0000950170-24-125582.md) | [91.6](/filings/0001193125-26-102364.md) | [96.0](/filings/0000950170-25-067125.md) | [128](/filings/0000950170-25-104181.md) | [123](/filings/0001193125-25-267126.md) | [172](/filings/0001193125-26-335335.md) | [204](/filings/0001193125-26-209250.md) | [206](/filings/0001193125-26-335335.md) |
| Long-term debt | $m | [57.6](/filings/0000950170-23-062166.md) | [55.6](/filings/0000950170-25-039495.md) | [52.7](/filings/0000950170-24-057177.md) | [49.7](/filings/0000950170-24-094128.md) | [46.7](/filings/0000950170-24-125582.md) | [43.8](/filings/0001193125-26-102364.md) | [40.8](/filings/0000950170-25-067125.md) | [57.8](/filings/0000950170-25-104181.md) | [54.9](/filings/0001193125-25-267126.md) | [126](/filings/0001193125-26-335335.md) | [149](/filings/0001193125-26-209250.md) | [150](/filings/0001193125-26-335335.md) |
| Current portion of debt | $m | [7.9](/filings/0000950170-23-062166.md) | [7.9](/filings/0000950170-25-039495.md) | [8.9](/filings/0000950170-24-057177.md) | [9.9](/filings/0000950170-24-094128.md) | [10.9](/filings/0000950170-24-125582.md) | [11.9](/filings/0001193125-26-102364.md) | [11.9](/filings/0000950170-25-067125.md) | [11.9](/filings/0000950170-25-104181.md) | [11.9](/filings/0001193125-25-267126.md) | [2.7](/filings/0001193125-26-335335.md) | [0.0](/filings/0001193125-26-209250.md) | [0.0](/filings/0001193125-26-335335.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001193125-26-102364.md) | [0.2](/filings/0001193125-26-209250.md) | [0.2](/filings/0001193125-26-335335.md) |
| Shareholders' equity | $m | [243](/filings/0000950170-24-125582.md) | [250](/filings/0001193125-26-102364.md) | [254](/filings/0000950170-25-104181.md) | [255](/filings/0001193125-25-267126.md) | [275](/filings/0001193125-25-267126.md) | [257](/filings/0001193125-26-335335.md) | [258](/filings/0001193125-26-335335.md) | [255](/filings/0001193125-26-335335.md) | [261](/filings/0001193125-25-267126.md) | [263](/filings/0001193125-26-335335.md) | [264](/filings/0001193125-26-335335.md) | [265](/filings/0001193125-26-335335.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.5 d](/filings/0000950170-24-125582.md) | [21.5 d](/filings/0001193125-26-102364.md) | [14.3](/filings/0000950170-25-067125.md) | [0.2 d](/filings/0000950170-25-104181.md) | [28.6 d](/filings/0001193125-25-267126.md) | [0.7 d](/filings/0001193125-26-102364.md) | [9.1](/filings/0001193125-26-209250.md) | [8.2 d](/filings/0001193125-26-335335.md) | [12.7 d](/filings/0001193125-25-267126.md) | [0.3 d](/filings/0001193125-26-102364.md) | [15.8](/filings/0001193125-26-209250.md) | [14.6 d](/filings/0001193125-26-335335.md) |
| Capital expenditure | $m | [15.8](/filings/0000950170-24-125582.md) | [17.7 d](/filings/0001193125-26-102364.md) | [22.0](/filings/0000950170-25-067125.md) | [18.8](/filings/0000950170-25-104181.md) | [12.6](/filings/0001193125-25-267126.md) | [9.0 d](/filings/0001193125-26-102364.md) | [11.6](/filings/0001193125-26-209250.md) | [33.7](/filings/0001193125-26-335335.md) | [29.8](/filings/0001193125-25-267126.md) | [41.4 d](/filings/0001193125-26-102364.md) | [30.9](/filings/0001193125-26-209250.md) | [24.7](/filings/0001193125-26-335335.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [143](/filings/0000950170-23-062166.md) | [142](/filings/0000950170-24-057177.md) | [142](/filings/0000950170-24-094128.md) | [142](/filings/0000950170-24-125582.md) | [142](/filings/0000950170-25-067125.md) | [142](/filings/0000950170-25-104181.md) | [143](/filings/0001193125-25-267126.md) | [143](/filings/0001193125-26-209250.md) | [143](/filings/0001193125-26-335335.md) | [143](/filings/0001193125-25-267126.md) | [143](/filings/0001193125-26-209250.md) | [144](/filings/0001193125-26-335335.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 142,341,139 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335335.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.